Meta-analysis of lipid-lowering therapy in maintenance dialysis patients

Nephron - Clinical Practice

Volumn 124, Issue 3-4, 2013, Pages 209-217

  Green, Darren ^a,b   Ritchie, James P ^a,b   Kalra, Philip A ^a,b  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Atherosclerosis; Cardiovascular; Cholesterol; Dialysis; Ezetimibe; Lipid lowering therapy; Meta analysis; Statin

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; EZETIMIBE PLUS SIMVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ROSUVASTATIN;

ALL CAUSE MORTALITY; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAINTENANCE THERAPY; META ANALYSIS; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CAUSE OF DEATH; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; STROKE;

EID: 84892412061     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000357676     Document Type: Article

References (25)

1. Cheung AK: Is lipid control necessary in hemodialysis patients? Clin J Am Soc Nephrol 2009; 4(Suppl 1):S95-S101.
2. Green D, Panayotova R, Ritchie JP, O'Riordan E, McDonald J: Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe? J Ren Care 2012; 38: 138-146.
3. Lee T, Lee R: Ask the doctors. I am 71 years old, have chronic kidney failure, and am on dialysis. I know my overall outlook is not good, and I wonder whether it is worth it to take a statin to control my cholesterol. Harv Heart Lett 2012; 23: 2.
4. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al; SHARP Investigators: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192.
5. Stack AG, Bloembergen WE: Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. J Am Soc Nephrol 2001; 12: 1516-1523. (Pubitemid 32666335)
6. Foley RN, Parfrey PS, Harnett JD, Kent GM: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Coll Cardiol 1995; 5: 2024-2031.
7. Paoletti E, Specchia C, Di Maio G, et al: The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004; 19: 1829-1834. (Pubitemid 38961395)
8. Krane V, Heinrich F, Meesmann M, et al: Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 2009; 4: 394-400.
9. Kovesdy C, Regidor D, Mehrotra R, Jing J: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2004; 2: 999-1007.
10. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E, German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248. (Pubitemid 41058323)
11. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al; AURORA Study Group: Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407.
12. Strippoli GFM, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC: Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 2008; 36: 645-651. (Pubitemid 351481234)
13. Barylski M, Nikfar S, Mikhailidis DP, Toth PP, Salari P, Ray KK, Pencina MJ, Rizzo M, Rysz J, Abdollahi M, Nicholls SJ, Banach M, Lipid and Blood Pressure Meta-Analysis Collaboration Group: Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy - a meta-analysis of 11 randomized controlled trials involving 21,295 participants. Pharmacol Res 2013; 72: 35-44.
14. Hou W, Lv J, Perkovic V, Yang L, Zhao N, Jardine MJ, Cass A, Zhang H, Wang H: Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J 2013; 34: 1807-1817.
15. Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF: Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012; 157: 263-275.
16. Law MR, Wald NJ, Thompson SG: By how much and how quickly does reduction in serum-cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367-372. (Pubitemid 24078498)
17. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG: Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006; 6: 50.
18. Bax L, Yu LM, Ikeda N, Moons KG: A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Med Res Methodol 2007; 7: 40.
19. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA: Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011; 32: 1484-1492.
20. Joyal D, Filion KB, Eisenberg MJ: Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis. Am Heart J 2010; 159: 159-169.e4.
21. Nikolic D, Nikfar S, Salari P, Rizzo M, Ray KK, Pencina MJ, Mikhailidis DP, Toth PP, Nicholls SJ, Rysz J, Abdollahi M, Banach M, Lipid and Blood Pressure Meta-Analysis Collaboration Group: Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Curr Med Res Opin 2013; 29: 435-451.
22. Nakano T, Ninomiya T, Sumiyoshi S, et al: Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama Study. Am J Kidney Dis 2010; 55: 21-30.
23. Green D, Roberts PR, New DI, Kalra PA: Sudden cardiac death in hemodialysis patients: an in-depth review. Am J Kidney Dis 2011; 57: 921-929.
24. Erickson KF, Japa S, Owens DK, Chertow GM, Garber AM, Goldhaber-Fiebert JD: Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol 2013; 61: 1250-1258.
25. Greving JP, Visseren FL, de Wit GA, Algra A: Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ 2011; 342:d1672.